Volume 27, Number 12—December 2021
Dispatch
SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
Table 2
Comparison of diagnostic sensitivity and specificity of the RBD-ELISA and VNT in a study of SARS-CoV-2 seroprevalence among domestic cats during the first pandemic wave, Europe, April–August 2020*
Test results | Value |
---|---|
RBD-ELISA sensitivity, % (95% CI) | 90.6 (90.0–91.2) |
RBD-ELISA specificity, % (95% CI) | 99.8 (99.8–99.8) |
No. positive (%; 95% CI), n = 2,160 | |
RBD-ELISA and VNT | 87 (4.0; 3.2–4.9) |
RBD-ELISA only | 92 (4.3; 3.5–5.2) |
VNT only | 96 (4.4; 3.6–5.4) |
*A total of 5 samples were positive with RBD-ELISA and negative with VNT; 9 samples were positive with VNT but negative with RBD-ELISA. RBD-ELISA, receptor-binding domain–specific ELISA; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; VNT, virus neutralization test.
1These authors contributed equally to this article.
Page created: September 01, 2021
Page updated: November 19, 2021
Page reviewed: November 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.